申请人:Iinuma Munekazu
公开号:US20130225837A1
公开(公告)日:2013-08-29
An object of the present invention is to provide a novel trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof and to provide a pharmaceutical agent which contains said compound as an active ingredient and has a highly safe neurotrophic factor-like activity or an alleviating action for side effect induced by administration of anti-cancer agents. The trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof which is the compound of the present invention is specifically represented by the formula (1):
(In the formula, Y is —O—, —NR— or —S—, R is hydrogen atom, alkyl group, dialkylaminoalkyl group or the like and W is a substituent such as dialkylaminoalkyl group) and has a quite high usefulness as a pharmaceutical agent such as a preventive or therapeutic agent for dementia, Alzheimer's disease, Parkinson's disease, depression, etc., a treating or repairing agent for spinal cord injury.
本发明的目的是提供一种新的反式-2-癸烯酸衍生物或其药用盐,并提供一种包含该化合物作为活性成分并具有高度安全的神经营养因子样活性或对抗癌药物引起的副作用的缓解作用的药物制剂。本发明的反式-2-癸烯酸衍生物或其药用盐具体由化学式(1)表示:(在该式中,Y为—O—、—NR—或—S—,R为氢原子、烷基、二烷基氨基烷基或类似物,W为二烷基氨基烷基等取代基),作为一种药用制剂,具有预防或治疗痴呆症、阿尔茨海默病、帕金森病、抑郁症等的药物,以及治疗或修复脊髓损伤的药物,具有非常高的实用性。